Neural system-enriched gene expression: Relationship to biological pathways and neurological diseases

Physiological Genomics

Volumn 18, Issue , 2004, Pages 167-183

  Zhang, Jianhua ^a   Moseley, Amy ^a   Jegga, Anil G ^b   Gupta, Ashima ^b   Witte, David P ^b   Sartor, Maureen ^a   Medvedovic, Mario ^a   Williams, Sarah S ^b   Ley Ebert, Cathy ^b   Coolen, Lique M ^a   Egnaczyk, Gregory ^a   Genter, Mary Beth ^a   Lehman, Michael ^a   Lingrel, Jerry ^a   Maggio, John ^a   Parysek, Linda ^a   Walsh, Ryan ^a   Xu, Ming ^a   Aronow, Bruce J ^b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Global context; Microarray; Nervous system

Indexed keywords

MEMBRANE PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOSKELETON; ENZYME METABOLISM; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ANALYSIS; INTRACELLULAR TRANSPORT; MENTAL DEFICIENCY; MENTAL DISEASE; MOUSE; NERVE DEGENERATION; NERVOUS SYSTEM FUNCTION; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA METABOLISM; RNA TRANSCRIPTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; CEREBELLUM; CLUSTER ANALYSIS; GANGLIA, SPINAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HYPOTHALAMUS; MALE; MICE; MICE, INBRED C57BL; NERVOUS SYSTEM; NERVOUS SYSTEM DISEASES; NUCLEUS ACCUMBENS; OLFACTORY PATHWAYS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ORGAN SPECIFICITY; SPINAL CORD;

ANIMALIA; EUKARYOTA; TRIXIS;

EID: 4844227992     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00220.2003     Document Type: Article

References (93)

1. Baas PW. Microtubules and axonal growth. Curr Opin Cell Biol 9: 29-36, 1997.
2. Bates MD, Erwin CR, Sanford LP, Wiginton D, Bezerra JA, Schatzman LC, Jegga AG, Ley-Ebert C, Williams SS, Steinbrecher KA, Warner BW, Cohen MB, and Aronow BJ. Novel genes and functional relationships in the adult mouse gastrointestinal tract identified by microarray analysis. Gastroenterology 122: 1467-1482, 2002.
3. Belecky-Adams T, Wight DC, Kopchick JJ, and Parysek LM. Intragenic sequences are required for cell type-specific and injury-induced expression of the rat peripherin gene. J Neurosci 13: 5056-5065, 1993.
4. Bennett MR, Rizvi TA, Karyala S, McKinnon RD, and Ratner N. Aberrant growth and differentiation of oligodendrocyte progenitors in neurofibromatosis type 1 mutants. J Neurosci 23: 7207-7217, 2003.
5. Blalock EM, Chen KC, Sharrow K, Herman JP, Porter NM, Foster TC, and Landfield PW. Gene microarrays in hippocampal aging: statistical profiling identifies novel processes correlated with cognitive impairment. J Neurosci 23: 3807-3819, 2003.
6. Brown VM, Ossadtchi A, Khan AH, Cherry SR, Leahy RM, and Smith DJ. High-throughput imaging of brain gene expression. Genome Res 12: 244-254, 2002.
7. Chavez JC and LaManna JC. Activation of hypoxia-inducible factor-1 in the rat cerebral cortex after transient global ischemia: potential role of insulin-like growth factor-1. J Neurosci 22: 8922-8931, 2002.
8. Cowles CR, Hirschhorn JN, Altshuler D, and Lander ES. Detection of regulatory variation in mouse genes. Nat Genet 32: 432-427, 2002.
9. Dawson TM and Dawson VL. Molecular pathways of neurodegeneration in Parkinson's disease. Science 302: 819-822, 2003.
10. De-Fraja C, Conti L, Magrassi L, Govoni S, and Cattaneo E. Members of the JAK/STAT proteins are expressed and regulated during development in the mammalian forebrain. J Neurosci Res 54: 320-330, 1998.
11. Dehmelt L, Smart FM, Ozer RS, and Halpain S. The role of microtubule-associated protein 2c in the reorganization of microtubules and lamellipodia during neurite initiation. J Neurosci 23: 9479-9490, 2003.
12. Feng L, Hatten ME, and Heintz N. Brain lipid-binding protein (BLBP): a novel signaling system in the developing mammalian CNS. Neuron 12: 895-908, 1994.
13. Genin A, Davis S, Meziane H, Doyere V, Jeromin A, Roder J, Mallet J, and Laroche S. Regulated expression of the neuronal calcium sensor-1 gene during long-term potentiation in the dentate gyrus in vivo. Neuroscience 106: 571-577, 2001.
14. Genter MB, Van Veldhoven PP, Jegga A, Sakthivel B, Kong S, Stanley K, Witte DP, Ebert CL, and Aronow BJ. Microarray-based discovery of highly-expressed olfactory mucosal genes: potential roles in the various functions of the olfactory system. Physiol Genomics 16: 67-81, 2003. First published October 21, 2003; 10.1152/physiolgenomics.00117.2003.
15. Giasson BI, Duda JE, Forman MS, Lee VM, and Trojanowski JQ. Prominent perikaryal expression of alpha- and beta-synuclein in neurons of dorsal root ganglion and in medullary neurons. Exp Neurol 172: 354-362, 2001.
16. Gonzalez-Maeso J, Yuen T, Ebersole BJ, Wurmbach E, Lira A, Zhou M, Weisstaub N, Hen R, Gingrich JA, and Sealfon SC. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex. J Neurosci 23: 8836-8843, 2003.
17. 2+-transporting ATPase that is expressed predominantly in brain and skeletal muscle. J Biol Chem 264: 18569-18576, 1989.
18. Hamamori Y, Sartorelli V, Ogryzko V, Puri PL, Wu HY, Wang JY, Nakatani Y, and Kedes L. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96: 405-413, 1999.
19. Harigaya Y, Shoji M, Shirao T, and Hirai S. Disappearance of actin-binding protein, drebrin, from hippocampal synapses in Alzheimer's disease. J Neurosci Res 43: 87-92, 1996.
20. Hida H, Jung CG, Wu CZ, Kim HJ, Kodama Y, Masuda T, and Nishino H. Pleiotrophin exhibits a trophic effect on survival of dopaminergic neurons in vitro. Eur J Neurosci 17: 2127-2134, 2003.
21. Higuchi M, Lee VM, and Trojanowski JQ. Tau and axonopathy in neurodegenerative disorders. Neuromolecular Med 2: 131-150, 2002.
22. Hopf FW, Cascini MG, Gordon AS, Diamond I, and Bonci A. Cooperative activation of dopamine D1 and D2 receptors increases spike firing of nucleus accumbens neurons via G-protein βγ subunits. J Neurosci 23: 5079-5087, 2003.
23. Iwai K, Yamanaka K, Kamura T, Minato N, Conaway RC, Conaway JW, Klausner RD, and Pause A. Identification of the von Hippel-Lindau tumor-suppressor protein as part of an active E3 ubiquitin ligase complex. Proc Natl Acad Sci USA 96: 12436-12441, 1999.
24. Jacobson M. Developmental Neurobiology. New York: Plenum, 1991.
25. Jiang CH, Tsien JZ, Schultz PG, and Hu Y. The effects of aging on gene expression in the hypothalamus and cortex of mice. Proc Natl Acad Sci USA 98: 1930-1934, 2001.
26. Jiang X, Hanna Z, Kaouass M, Girard L, and Jolicoeur P. Ahi-1, a novel gene encoding a modular protein with WD40-repeat and SH3 domains, is targeted by the Ahi-1 and Mis-2 provirus integrations. J Virol 76: 9046-9059, 2003.
27. Kawano Y and Kypta R. Secreted antagonists of the Wnt signalling pathway. J Cell Sci 116: 2627-2634, 2003.
28. Kedra D, Pan HQ, Seroussi E, Fransson I, Guilbaud C, Collins JE, Dunham I, Blennow E, Roe BA, Piehl F, and Dumanski JP. Characterization of the human synaptogyrin gene family. Hum Genet 103: 131-141, 1998.
29. Kelley-Loughnane N, Sabla GE, Ley-Ebert C, Aronow BJ, and Bezerra JA. Independent and overlapping transcriptional activation during liver development and regeneration in mice. Hepatology 35: 525-534, 2002.
30. Kennedy JL, Farrer LA, Andreasen NC, Mayeux R, and St George-Hyslop P. The genetics of adult-onset neuropsychiatric disease: complexities and conundra? Science 302: 822-826, 2003.
31. Kim JH, Lee HK, Takamiya K, and Huganir RL. The role of synaptic GTPase-activating protein in neuronal development and synaptic plasticity. J Neurosci 23: 1119-1124, 2003.
32. Kneussel M and Betz H. Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model. Trends Neurosci 23: 429-435, 2000.
33. Krezel W, Ghyselinck N, Samad TA, Dupe V, Kastner P, Borrelli E, and Chambon P. Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. Science 279: 863-867, 1998.
34. Krupnik VE, Sharp JD, Jiang C, Robison K, Chickering TW, Amaravadi L, Brown DE, Guyot D, Mays G, Leiby K, Chang B, Duong T, Goodearl AD, Gearing DP, Sokol SY, and McCarthy SA. Functional and structural diversity of the human Dickkopf gene family. Gene 238: 301-313, 1999.
35. Langnaese K, Kloos DU, Wehnert M, Seidel B, and Wieacker P. Expression pattern and further characterization of human MAGED2 and identification of rodent orthologues. Cytogenet Cell Genet 94: 233-240, 2001.
36. Lansbury PT Jr and Brice A. Genetics of Parkinson's disease and biochemical studies of implicated gene products. Curr Opin Cell Biol 14: 653-660, 2002.
37. Lee CK, Weindruch R, and Prolla TA. Gene-expression profile of the ageing brain in mice. Nat Genet 25: 294-297, 2000.
38. Lee DK, George SR, Evans JF, Lynch KR, and O'Dowd BF. Orphan G protein-coupled receptors in the CNS. Curr Opin Pharmacol 1: 31-39, 2001.
39. Lee SJ. Expression of growth/differentiation factor 1 in the nervous system: conservation of a bicistronic structure. Proc Natl Acad Sci USA 88: 4250-4254, 1991.
40. Li SH, Yu ZX, Li CL, Nguyen HP, Zhou YX, Deng C, and Li XJ. Lack of huntingtin-associated protein-1 causes neuronal death resembling hypothalamic degeneration in Huntington's disease. J Neurosci 23: 6956-6964, 2003.
41. Li XJ, Li SH, Sharp AH, Nucifora FC Jr, Schilling G, Lanahan A, Worley P, Snyder SH, and Ross CA. A huntingtin-associated protein enriched in brain with implications for pathology. Nature 378: 398-402, 1995.
42. Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, Milbrandt J, and Deuel TF. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science 250: 1690-1694, 1990.
43. Lin MZ and Greenberg ME. Orchestral maneuvers in the axon: trio and the control of axon guidance. Cell 101: 239-242, 2000.
44. Liu Y, Fallon L, Lashuel HA, Liu Z, and Lansbury PT Jr. The UCH-L1 gene encodes two opposing enzymatic activities that affect alpha-synuclein degradation and Parkinson's disease susceptibility. Cell 111: 209-218, 2002.
45. Lonart G, Schoch S, Kaeser PS, Larkin CJ, Sudhof TC, and Linden DJ. Phosphorylation of RIM1α by PKA triggers presynaptic long-term potentiation at cerebellar parallel fiber synapses. Cell 115: 49-60, 2003.
46. Maillet M, Robert SJ, Cacquevel M, Gastineau M, Vivien D, Bertoglio J, Zugaza JL, Fischmeister R, and Lezoualc'h F. Crosstalk between Rap1 and Rac regulates secretion of sAPPα. Nat Cell Biol 5: 633-639, 2003.
47. Marillat V, Cases O, Nguyen-Ba-Charvet KT, Tessier-Lavigne M, Sotelo C, and Chedotal A. Spatiotemporal expression patterns of slit and robo genes in the rat brain. J Comp Neurol 442: 130-155, 2002.
48. Matsuoka Y, Li X, and Bennett V. Adducin is an in vivo substrate for protein kinase C: phosphorylation in the MARCKS-related domain inhibits activity in promoting spectrin-actin complexes and occurs in many cells, including dendritic spines of neurons. J Cell Biol 142: 485-497, 1998.
49. Maxwell PH, Wiesener MS, Chang GW, Clifford SC, Vaux EC, Cockman ME, Wykoff CC, Pugh CW, Maher ER, and Ratcliffe PJ. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399: 271-275, 1999.
50. Middleton FA, Mirnics K, Pierri JN, Lewis DA, and Levitt P. Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci 22: 2718-2729, 2002.
51. Miki R, Kadota K, Bono H, Mizuno Y, Tomaru Y, Carninci P, Itoh M, Shibata K, Kawai J, Konno H, Watanabe S, Sato K, Tokusumi Y, Kikuchi N, Ishii Y, Hamaguchi Y, Nishizuka I, Goto H, Nitanda H, Satomi S, Yoshiki A, Kusakabe M, DeRisi JL, Eisen MB, Iyer VR, Brown PO, Muramatsu M, Shimada H, Okazaki Y, and Hayashizaki Y. Delineating developmental and metabolic pathways in vivo by expression profiling using the RIKEN set of 18,816 full-length enriched mouse cDNA arrays. Proc Natl Acad Sci USA 98: 2199-2204, 2001.
52. Mirnics K, Middleton FA, Marquez A, Lewis DA, and Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28: 53-67, 2000.
53. Mody M, Cao Y, Cui Z, Tay KY, Shyong A, Shimizu E, Pham K, Schultz P, Welsh D, and Tsien JZ. Genome-wide gene expression profiles of the developing mouse hippocampus. Proc Natl Acad Sci USA 98: 8862-8867, 2001.
54. Murata H, Tajima N, Nagashima Y, Yao M, Baba M, Goto M, Kawamoto S, Yamamoto I, Okuda K, and Kanno H. Von Hippel-Lindau tumor suppressor protein transforms human neuroblastoma cells into functional neuron-like cells. Cancer Res 62: 7004-7011, 2002.
55. Orlowski J and Lingrel JB. Tissue-specific and developmental regulation of rat Na,K-ATPase catalytic a isoform and beta subunit mRNAs. J Biol Chem 263: 10436-10442, 1988.
56. Pavlidis P and Noble WS. Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol 2: RESEARCH0042, 2001.
57. Penn SG, Rank DR, Hanzel DK, and Barker DL. Mining the human genome using microarrays of open reading frames. Nat Genet 26: 315-318, 2000.
58. Pomeroy SL, Tamayo P, Gaasenbeek M, Sturla LM, Angelo M, McLaughlin ME, Kim JY, Goumnerova LC, Black PM, Lau C, Allen JC, Zagzag D, Olson JM, Curran T, Wetmore C, Biegel JA, Poggio T, Mukherjee S, Rifkin R, Califano A, Stolovitzky G, Louis DN, Mesirov JP, Lander ES, and Golub TR. Prediction of central nervous system embryonal tumour outcome based on gene expression. Nature 415: 436-442, 2002.
59. Poser S, Impey S, Xia Z, and Storm DR. Brain-derived neurotrophic factor protection of cortical neurons from serum withdrawal-induced apoptosis is inhibited by cAMP. J Neurosci 23: 4420-4427, 2003.
60. Rampon C, Jiang CH, Dong H, Tang YP, Lockhart DJ, Schultz PG, Tsien JZ, and Hu Y. Effects of environmental enrichment on gene expression in the brain. Proc Natl Acad Sci USA 97: 12880-12884, 2000.
61. Rankin CT, Bunton T, Lawler AM, and Lee SJ. Regulation of left-right patterning in mice by growth/differentiation factor-1. Nat Genet 24: 262-265, 2000.
62. Rebhan M, Chalifa-Caspi V, Prilusky J, and Lancet D. GeneCards: a novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics 14: 656-664, 1998.
63. Reyes TM, Walker JR, DeCino C, Hogenesch JB, and Sawchenko PE. Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J Neurosci 23: 5607-5616, 2003.
64. Rocchi A, Pellegrini S, Siciliano G, and Murri L. Causative and susceptibility genes for Alzheimer's disease: a review. Brain Res Bull 61: 1-24, 2003.
65. van Rossum D and Hanisch UK. Cytoskeletal dynamics in dendritic spines: direct modulation by glutamate receptors? Trends Neurosci 22: 290-295, 1999.
66. Samad TA, Krezel W, Chambon P, and Borrelli E. Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. Proc Natl Acad Sci USA 94: 14349-14354, 1997.
67. Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, and Barlow C. Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci USA 97: 11038-11043, 2000.
68. Schlessinger J. SH2/SH3 signaling proteins. Curr Opin Genet Dev 4: 25-30, 1994.
69. Selkoe DJ and Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 43: 545-584, 2003.
70. Shah JV and Cleveland DW. Slow axonal transport: fast motors in the slow lane. Curr Opin Cell Biol 14: 58-62, 2002.
71. Sharp FR, Bergeron M, and Bernaudin M. Hypoxia-inducible factor in brain. Adv Exp Med Biol 502: 273-291, 2001.
72. Shim KS and Lubec G. Drebrin, a dendritic spine protein, is manifold decreased in brains of patients with Alzheimer's disease and Down syndrome. Neurosci Lett 324: 209-212, 2002.
73. Shirao T and Sekino Y. Clustering and anchoring mechanisms of molecular constituents of postsynaptic scaffolds in dendritic spines. Neurosci Res 40: 1-7, 2001.
74. Su AI, Cooke MP, Ching KA, Hakak Y, Walker JR, Wiltshire T, Orth AP, Vega RG, Sapinoso LM, Moqrich A, Patapoutian A, Hampton GM, Schultz PG, and Hogenesch JB. Large-scale analysis of the human and mouse transcriptomes. Proc Natl Acad Sci USA 99: 4465-4470, 2002.
75. Tamayo P, Slonim D, Mesirov J, Zhu Q, Kitareewan S, Dmitrovsky E, Lander ES, and Golub TR. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 96: 2907-2912, 1999.
76. Tang Y, Lu A, Aronow BJ, and Sharp FR. Blood genomic responses differ after stroke, seizures, hypoglycemia, and hypoxia: blood genomic fingerprints of disease. Ann Neurol 50: 699-707, 2001.
77. Tang Y, Lu A, Aronow BJ, Wagner KR, and Sharp FR. Genomic responses of the brain to ischemic stroke, intracerebral haemorrhage, kainate seizures, hypoglycemia, and hypoxia. Eur J Neurosci 15: 1937-1952, 2002.
78. Tang Y, Nee AC, Lu A, Ran R, and Sharp FR. Blood genomic expression profile for neuronal injury. J Cereb Blood Flow Metab 23: 310-319, 2003.
79. Tomita S, Ueno M, Sakamoto M, Kitahama Y, Ueki M, Maekawa N, Sakamoto H, Gassmann M, Kageyama R, Ueda N, Gonzalez FJ, and Takahama Y. Defective brain development in mice lacking the Hif-1α gene in neural cells. Mol Cell Biol 23: 6739-6749, 2003.
80. Troy CM, Muma NA, Greene LA, Price DL, and Shelanski ML. Regulation of peripherin and neurofilament expression in regenerating rat motor neurons. Brain Res 529: 232-238, 1990.
81. Tuominen M and Leppaluoto J. Peptides and neurotransmission in the central nervous system. Med Biol 65: 137-142, 1987.
82. Waltereit R and Weller M. Signaling from cAMP/PKA to MAPK and synaptic plasticity. Mol Neurobiol 27: 99-106, 2003.
83. Warrington JA, Nair A, Mahadevappa M, and Tsyganskaya M. Comparison of human adult and fetal expression and identification of 535 housekeeping/ maintenance genes. Physiol Genomics 2: 143-147, 2000.
84. Watase K and Zoghbi HY. Modelling brain diseases in mice: the challenges of design and analysis. Nat Rev Genet 4: 296-307, 2003.
85. Wen X, Fuhrman S, Michaels GS, Carr DB, Smith S, Barker JL, and Somogyi R. Large-scale temporal gene expression mapping of central nervous system development. Proc Natl Acad Sci USA 95: 334-339, 1998.
86. Wendler WM, Kremmer E, Forster R, and Winnacker EL. Identification of pirin, a novel highly conserved nuclear protein. J Biol Chem 272: 8482-8489, 1997.
87. Wisniewski T, Lalowski M, Baumann M, Rauvala H, Raulo E, Nolo R, and Frangione B. HB-GAM is a cytokine present in Alzheimers and Down's syndrome lesions. Neuroreport 7: 667-671, 1996.
88. Witte DP, Aronow BJ, Dry JK, and Harmony JAK. Temporally and spatially restricted expression of apolipoprotein J in the developing heart defines discrete stages of valve morphogenesis. Dev Dyn 201: 290-296, 1994.
89. Xu W, Edmondson DG, Evrard YA, Wakamiya M, Behringer RR, and Roth SY. Loss of Gcn512 leads to increased apoptosis and mesodermal defects during mouse development. Nat Genet 26: 229-232, 2000.
90. Zetterstrom RH, Lindqvist E, Mata de Urquiza A, Tomac A, Eriksson U, Perlmann T, and Olson L. Role of retinoids in the CNS: differential expression of retinoid binding proteins and receptors and evidence for presence of retinoic acid. Eur J Neurosci 11: 407-416, 1999.
91. Zhao X, Lein ES, He A, Smith SC, Aston C, and Gage FH. Transcriptional profiling reveals strict boundaries between hippocampal subregions. J Comp Neurol 441: 187-196, 2001.
92. Zirlinger M, Kreiman G, and Anderson DJ. Amygdala-enriched genes identified by microarray technology are restricted to specific amygdaloid subnuclei. Proc Natl Acad Sci USA 98: 5270-5275, 2001.
93. Zoghbi HY. Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302: 826-830, 2003.